nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—Joint injury—Vandetanib—thyroid cancer	0.15	0.225	CcSEcCtD
Hydrocodone—CYP3A4—Vandetanib—thyroid cancer	0.0957	0.286	CbGbCtD
Hydrocodone—CYP2D6—Sorafenib—thyroid cancer	0.0907	0.272	CbGbCtD
Hydrocodone—CYP3A4—Sorafenib—thyroid cancer	0.0577	0.173	CbGbCtD
Hydrocodone—CYP2D6—Doxorubicin—thyroid cancer	0.055	0.165	CbGbCtD
Hydrocodone—CYP3A4—Doxorubicin—thyroid cancer	0.035	0.105	CbGbCtD
Hydrocodone—Gastrooesophageal reflux disease—Sorafenib—thyroid cancer	0.0105	0.0158	CcSEcCtD
Hydrocodone—Lethargy—Vandetanib—thyroid cancer	0.0105	0.0157	CcSEcCtD
Hydrocodone—Drug interaction—Sorafenib—thyroid cancer	0.0103	0.0154	CcSEcCtD
Hydrocodone—Dehydration—Vandetanib—thyroid cancer	0.00953	0.0143	CcSEcCtD
Hydrocodone—Hypokalaemia—Vandetanib—thyroid cancer	0.00933	0.014	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00824	0.0124	CcSEcCtD
Hydrocodone—Urinary tract infection—Vandetanib—thyroid cancer	0.00768	0.0115	CcSEcCtD
Hydrocodone—Pain in extremity—Sorafenib—thyroid cancer	0.00692	0.0104	CcSEcCtD
Hydrocodone—Mood swings—Sorafenib—thyroid cancer	0.00655	0.00984	CcSEcCtD
Hydrocodone—Angiopathy—Vandetanib—thyroid cancer	0.00644	0.00966	CcSEcCtD
Hydrocodone—Dehydration—Sorafenib—thyroid cancer	0.00643	0.00966	CcSEcCtD
Hydrocodone—Mediastinal disorder—Vandetanib—thyroid cancer	0.00639	0.0096	CcSEcCtD
Hydrocodone—Hypokalaemia—Sorafenib—thyroid cancer	0.00629	0.00945	CcSEcCtD
Hydrocodone—Mental disorder—Vandetanib—thyroid cancer	0.00621	0.00933	CcSEcCtD
Hydrocodone—Malnutrition—Vandetanib—thyroid cancer	0.00617	0.00927	CcSEcCtD
Hydrocodone—Muscle spasms—Vandetanib—thyroid cancer	0.00594	0.00891	CcSEcCtD
Hydrocodone—Tremor—Vandetanib—thyroid cancer	0.00578	0.00869	CcSEcCtD
Hydrocodone—Abdominal discomfort—Sorafenib—thyroid cancer	0.00573	0.00861	CcSEcCtD
Hydrocodone—Cough—Vandetanib—thyroid cancer	0.00539	0.00809	CcSEcCtD
Hydrocodone—Convulsion—Vandetanib—thyroid cancer	0.00535	0.00803	CcSEcCtD
Hydrocodone—Arthralgia—Vandetanib—thyroid cancer	0.00526	0.00789	CcSEcCtD
Hydrocodone—Anxiety—Vandetanib—thyroid cancer	0.00524	0.00787	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00522	0.00784	CcSEcCtD
Hydrocodone—Dry mouth—Vandetanib—thyroid cancer	0.00514	0.00772	CcSEcCtD
Hydrocodone—Nervous system disorder—Vandetanib—thyroid cancer	0.00494	0.00742	CcSEcCtD
Hydrocodone—Thrombocytopenia—Vandetanib—thyroid cancer	0.00493	0.00741	CcSEcCtD
Hydrocodone—Skin disorder—Vandetanib—thyroid cancer	0.00489	0.00735	CcSEcCtD
Hydrocodone—Connective tissue disorder—Sorafenib—thyroid cancer	0.0047	0.00706	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00459	0.00689	CcSEcCtD
Hydrocodone—Insomnia—Vandetanib—thyroid cancer	0.00456	0.00684	CcSEcCtD
Hydrocodone—Paraesthesia—Vandetanib—thyroid cancer	0.00452	0.0068	CcSEcCtD
Hydrocodone—Dyspnoea—Vandetanib—thyroid cancer	0.00449	0.00675	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00435	0.00653	CcSEcCtD
Hydrocodone—Fatigue—Vandetanib—thyroid cancer	0.00434	0.00652	CcSEcCtD
Hydrocodone—Angiopathy—Sorafenib—thyroid cancer	0.00434	0.00652	CcSEcCtD
Hydrocodone—Mediastinal disorder—Sorafenib—thyroid cancer	0.00431	0.00648	CcSEcCtD
Hydrocodone—Constipation—Vandetanib—thyroid cancer	0.00431	0.00647	CcSEcCtD
Hydrocodone—Mental disorder—Sorafenib—thyroid cancer	0.00419	0.00629	CcSEcCtD
Hydrocodone—Malnutrition—Sorafenib—thyroid cancer	0.00417	0.00625	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00412	0.00619	CcSEcCtD
Hydrocodone—Muscle spasms—Sorafenib—thyroid cancer	0.004	0.00601	CcSEcCtD
Hydrocodone—Body temperature increased—Vandetanib—thyroid cancer	0.00398	0.00598	CcSEcCtD
Hydrocodone—Abdominal pain—Vandetanib—thyroid cancer	0.00398	0.00598	CcSEcCtD
Hydrocodone—Cough—Sorafenib—thyroid cancer	0.00363	0.00546	CcSEcCtD
Hydrocodone—Asthenia—Vandetanib—thyroid cancer	0.00362	0.00543	CcSEcCtD
Hydrocodone—Pruritus—Vandetanib—thyroid cancer	0.00357	0.00535	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00356	0.00535	CcSEcCtD
Hydrocodone—Neck pain—Epirubicin—thyroid cancer	0.00356	0.00535	CcSEcCtD
Hydrocodone—Myalgia—Sorafenib—thyroid cancer	0.00355	0.00533	CcSEcCtD
Hydrocodone—Arthralgia—Sorafenib—thyroid cancer	0.00355	0.00533	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00352	0.00529	CcSEcCtD
Hydrocodone—Dry mouth—Sorafenib—thyroid cancer	0.00347	0.00521	CcSEcCtD
Hydrocodone—Nervous system disorder—Sorafenib—thyroid cancer	0.00333	0.00501	CcSEcCtD
Hydrocodone—Dizziness—Vandetanib—thyroid cancer	0.00333	0.005	CcSEcCtD
Hydrocodone—Thrombocytopenia—Sorafenib—thyroid cancer	0.00333	0.005	CcSEcCtD
Hydrocodone—Skin disorder—Sorafenib—thyroid cancer	0.0033	0.00496	CcSEcCtD
Hydrocodone—Neck pain—Doxorubicin—thyroid cancer	0.0033	0.00495	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.0033	0.00495	CcSEcCtD
Hydrocodone—Vomiting—Vandetanib—thyroid cancer	0.0032	0.00481	CcSEcCtD
Hydrocodone—Rash—Vandetanib—thyroid cancer	0.00318	0.00477	CcSEcCtD
Hydrocodone—Dermatitis—Vandetanib—thyroid cancer	0.00317	0.00477	CcSEcCtD
Hydrocodone—Headache—Vandetanib—thyroid cancer	0.00316	0.00474	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.0031	0.00465	CcSEcCtD
Hydrocodone—Dyspnoea—Sorafenib—thyroid cancer	0.00303	0.00455	CcSEcCtD
Hydrocodone—Nausea—Vandetanib—thyroid cancer	0.00299	0.0045	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00293	0.00441	CcSEcCtD
Hydrocodone—Fatigue—Sorafenib—thyroid cancer	0.00293	0.0044	CcSEcCtD
Hydrocodone—Constipation—Sorafenib—thyroid cancer	0.00291	0.00437	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00278	0.00417	CcSEcCtD
Hydrocodone—Hot flush—Epirubicin—thyroid cancer	0.00273	0.0041	CcSEcCtD
Hydrocodone—Menopausal symptoms—Epirubicin—thyroid cancer	0.00271	0.00407	CcSEcCtD
Hydrocodone—Abdominal pain—Sorafenib—thyroid cancer	0.00269	0.00404	CcSEcCtD
Hydrocodone—Body temperature increased—Sorafenib—thyroid cancer	0.00269	0.00404	CcSEcCtD
Hydrocodone—Lethargy—Epirubicin—thyroid cancer	0.00261	0.00392	CcSEcCtD
Hydrocodone—Pain in extremity—Epirubicin—thyroid cancer	0.00256	0.00384	CcSEcCtD
Hydrocodone—Osteoarthritis—Epirubicin—thyroid cancer	0.00256	0.00384	CcSEcCtD
Hydrocodone—Hot flush—Doxorubicin—thyroid cancer	0.00253	0.0038	CcSEcCtD
Hydrocodone—Migraine—Epirubicin—thyroid cancer	0.00252	0.00378	CcSEcCtD
Hydrocodone—Affect lability—Epirubicin—thyroid cancer	0.00252	0.00378	CcSEcCtD
Hydrocodone—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00251	0.00376	CcSEcCtD
Hydrocodone—Hypersensitivity—Sorafenib—thyroid cancer	0.0025	0.00376	CcSEcCtD
Hydrocodone—Asthenia—Sorafenib—thyroid cancer	0.00244	0.00366	CcSEcCtD
Hydrocodone—Mood swings—Epirubicin—thyroid cancer	0.00242	0.00364	CcSEcCtD
Hydrocodone—Lethargy—Doxorubicin—thyroid cancer	0.00241	0.00362	CcSEcCtD
Hydrocodone—Pruritus—Sorafenib—thyroid cancer	0.00241	0.00361	CcSEcCtD
Hydrocodone—Dehydration—Epirubicin—thyroid cancer	0.00238	0.00357	CcSEcCtD
Hydrocodone—Osteoarthritis—Doxorubicin—thyroid cancer	0.00237	0.00355	CcSEcCtD
Hydrocodone—Pain in extremity—Doxorubicin—thyroid cancer	0.00237	0.00355	CcSEcCtD
Hydrocodone—Affect lability—Doxorubicin—thyroid cancer	0.00233	0.0035	CcSEcCtD
Hydrocodone—Migraine—Doxorubicin—thyroid cancer	0.00233	0.0035	CcSEcCtD
Hydrocodone—Hypokalaemia—Epirubicin—thyroid cancer	0.00233	0.00349	CcSEcCtD
Hydrocodone—Dizziness—Sorafenib—thyroid cancer	0.00225	0.00338	CcSEcCtD
Hydrocodone—Mood swings—Doxorubicin—thyroid cancer	0.00224	0.00336	CcSEcCtD
Hydrocodone—Dehydration—Doxorubicin—thyroid cancer	0.0022	0.0033	CcSEcCtD
Hydrocodone—Vomiting—Sorafenib—thyroid cancer	0.00216	0.00325	CcSEcCtD
Hydrocodone—Hypokalaemia—Doxorubicin—thyroid cancer	0.00215	0.00323	CcSEcCtD
Hydrocodone—Rash—Sorafenib—thyroid cancer	0.00214	0.00322	CcSEcCtD
Hydrocodone—Dermatitis—Sorafenib—thyroid cancer	0.00214	0.00322	CcSEcCtD
Hydrocodone—Headache—Sorafenib—thyroid cancer	0.00213	0.0032	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00205	0.00308	CcSEcCtD
Hydrocodone—Nausea—Sorafenib—thyroid cancer	0.00202	0.00303	CcSEcCtD
Hydrocodone—Drowsiness—Epirubicin—thyroid cancer	0.00197	0.00296	CcSEcCtD
Hydrocodone—Urinary tract infection—Epirubicin—thyroid cancer	0.00191	0.00288	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.0019	0.00285	CcSEcCtD
Hydrocodone—Agranulocytosis—Epirubicin—thyroid cancer	0.00184	0.00276	CcSEcCtD
Hydrocodone—Drowsiness—Doxorubicin—thyroid cancer	0.00182	0.00274	CcSEcCtD
Hydrocodone—Urinary tract infection—Doxorubicin—thyroid cancer	0.00177	0.00266	CcSEcCtD
Hydrocodone—Oedema peripheral—Epirubicin—thyroid cancer	0.00174	0.00262	CcSEcCtD
Hydrocodone—Connective tissue disorder—Epirubicin—thyroid cancer	0.00174	0.00261	CcSEcCtD
Hydrocodone—Agranulocytosis—Doxorubicin—thyroid cancer	0.0017	0.00255	CcSEcCtD
Hydrocodone—Oedema peripheral—Doxorubicin—thyroid cancer	0.00161	0.00242	CcSEcCtD
Hydrocodone—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00161	0.00241	CcSEcCtD
Hydrocodone—Angiopathy—Epirubicin—thyroid cancer	0.0016	0.00241	CcSEcCtD
Hydrocodone—Mediastinal disorder—Epirubicin—thyroid cancer	0.00159	0.00239	CcSEcCtD
Hydrocodone—Mental disorder—Epirubicin—thyroid cancer	0.00155	0.00233	CcSEcCtD
Hydrocodone—Malnutrition—Epirubicin—thyroid cancer	0.00154	0.00231	CcSEcCtD
Hydrocodone—Back pain—Epirubicin—thyroid cancer	0.00149	0.00224	CcSEcCtD
Hydrocodone—Angiopathy—Doxorubicin—thyroid cancer	0.00148	0.00223	CcSEcCtD
Hydrocodone—Muscle spasms—Epirubicin—thyroid cancer	0.00148	0.00222	CcSEcCtD
Hydrocodone—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00147	0.00221	CcSEcCtD
Hydrocodone—Mental disorder—Doxorubicin—thyroid cancer	0.00143	0.00215	CcSEcCtD
Hydrocodone—Malnutrition—Doxorubicin—thyroid cancer	0.00142	0.00214	CcSEcCtD
Hydrocodone—Back pain—Doxorubicin—thyroid cancer	0.00138	0.00207	CcSEcCtD
Hydrocodone—Muscle spasms—Doxorubicin—thyroid cancer	0.00137	0.00206	CcSEcCtD
Hydrocodone—Cough—Epirubicin—thyroid cancer	0.00134	0.00202	CcSEcCtD
Hydrocodone—Convulsion—Epirubicin—thyroid cancer	0.00133	0.002	CcSEcCtD
Hydrocodone—Myalgia—Epirubicin—thyroid cancer	0.00131	0.00197	CcSEcCtD
Hydrocodone—Arthralgia—Epirubicin—thyroid cancer	0.00131	0.00197	CcSEcCtD
Hydrocodone—Anxiety—Epirubicin—thyroid cancer	0.00131	0.00196	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.0013	0.00195	CcSEcCtD
Hydrocodone—Dry mouth—Epirubicin—thyroid cancer	0.00128	0.00192	CcSEcCtD
Hydrocodone—Cough—Doxorubicin—thyroid cancer	0.00124	0.00187	CcSEcCtD
Hydrocodone—Convulsion—Doxorubicin—thyroid cancer	0.00123	0.00185	CcSEcCtD
Hydrocodone—Nervous system disorder—Epirubicin—thyroid cancer	0.00123	0.00185	CcSEcCtD
Hydrocodone—Thrombocytopenia—Epirubicin—thyroid cancer	0.00123	0.00185	CcSEcCtD
Hydrocodone—Skin disorder—Epirubicin—thyroid cancer	0.00122	0.00183	CcSEcCtD
Hydrocodone—Hyperhidrosis—Epirubicin—thyroid cancer	0.00121	0.00182	CcSEcCtD
Hydrocodone—Myalgia—Doxorubicin—thyroid cancer	0.00121	0.00182	CcSEcCtD
Hydrocodone—Arthralgia—Doxorubicin—thyroid cancer	0.00121	0.00182	CcSEcCtD
Hydrocodone—Anxiety—Doxorubicin—thyroid cancer	0.00121	0.00181	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.0012	0.00181	CcSEcCtD
Hydrocodone—Dry mouth—Doxorubicin—thyroid cancer	0.00119	0.00178	CcSEcCtD
Hydrocodone—Hypotension—Epirubicin—thyroid cancer	0.00117	0.00176	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00114	0.00172	CcSEcCtD
Hydrocodone—Nervous system disorder—Doxorubicin—thyroid cancer	0.00114	0.00171	CcSEcCtD
Hydrocodone—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00114	0.00171	CcSEcCtD
Hydrocodone—Insomnia—Epirubicin—thyroid cancer	0.00114	0.00171	CcSEcCtD
Hydrocodone—Skin disorder—Doxorubicin—thyroid cancer	0.00113	0.0017	CcSEcCtD
Hydrocodone—Paraesthesia—Epirubicin—thyroid cancer	0.00113	0.00169	CcSEcCtD
Hydrocodone—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00112	0.00169	CcSEcCtD
Hydrocodone—Dyspnoea—Epirubicin—thyroid cancer	0.00112	0.00168	CcSEcCtD
Hydrocodone—Somnolence—Epirubicin—thyroid cancer	0.00112	0.00168	CcSEcCtD
Hydrocodone—Hypotension—Doxorubicin—thyroid cancer	0.00109	0.00163	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00108	0.00163	CcSEcCtD
Hydrocodone—Fatigue—Epirubicin—thyroid cancer	0.00108	0.00163	CcSEcCtD
Hydrocodone—Constipation—Epirubicin—thyroid cancer	0.00107	0.00161	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00106	0.00159	CcSEcCtD
Hydrocodone—Insomnia—Doxorubicin—thyroid cancer	0.00105	0.00158	CcSEcCtD
Hydrocodone—Paraesthesia—Doxorubicin—thyroid cancer	0.00104	0.00157	CcSEcCtD
Hydrocodone—Dyspnoea—Doxorubicin—thyroid cancer	0.00104	0.00156	CcSEcCtD
Hydrocodone—Somnolence—Doxorubicin—thyroid cancer	0.00103	0.00155	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00103	0.00154	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.001	0.00151	CcSEcCtD
Hydrocodone—Fatigue—Doxorubicin—thyroid cancer	0.001	0.0015	CcSEcCtD
Hydrocodone—Constipation—Doxorubicin—thyroid cancer	0.000994	0.00149	CcSEcCtD
Hydrocodone—Abdominal pain—Epirubicin—thyroid cancer	0.000993	0.00149	CcSEcCtD
Hydrocodone—Body temperature increased—Epirubicin—thyroid cancer	0.000993	0.00149	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000951	0.00143	CcSEcCtD
Hydrocodone—Hypersensitivity—Epirubicin—thyroid cancer	0.000926	0.00139	CcSEcCtD
Hydrocodone—Abdominal pain—Doxorubicin—thyroid cancer	0.000919	0.00138	CcSEcCtD
Hydrocodone—Body temperature increased—Doxorubicin—thyroid cancer	0.000919	0.00138	CcSEcCtD
Hydrocodone—Asthenia—Epirubicin—thyroid cancer	0.000901	0.00135	CcSEcCtD
Hydrocodone—Pruritus—Epirubicin—thyroid cancer	0.000889	0.00133	CcSEcCtD
Hydrocodone—Hypersensitivity—Doxorubicin—thyroid cancer	0.000856	0.00129	CcSEcCtD
Hydrocodone—Asthenia—Doxorubicin—thyroid cancer	0.000834	0.00125	CcSEcCtD
Hydrocodone—Dizziness—Epirubicin—thyroid cancer	0.000831	0.00125	CcSEcCtD
Hydrocodone—Pruritus—Doxorubicin—thyroid cancer	0.000822	0.00124	CcSEcCtD
Hydrocodone—Vomiting—Epirubicin—thyroid cancer	0.000799	0.0012	CcSEcCtD
Hydrocodone—Rash—Epirubicin—thyroid cancer	0.000792	0.00119	CcSEcCtD
Hydrocodone—Dermatitis—Epirubicin—thyroid cancer	0.000791	0.00119	CcSEcCtD
Hydrocodone—Headache—Epirubicin—thyroid cancer	0.000787	0.00118	CcSEcCtD
Hydrocodone—Dizziness—Doxorubicin—thyroid cancer	0.000769	0.00115	CcSEcCtD
Hydrocodone—Nausea—Epirubicin—thyroid cancer	0.000746	0.00112	CcSEcCtD
Hydrocodone—Vomiting—Doxorubicin—thyroid cancer	0.000739	0.00111	CcSEcCtD
Hydrocodone—Rash—Doxorubicin—thyroid cancer	0.000733	0.0011	CcSEcCtD
Hydrocodone—Dermatitis—Doxorubicin—thyroid cancer	0.000732	0.0011	CcSEcCtD
Hydrocodone—Headache—Doxorubicin—thyroid cancer	0.000728	0.00109	CcSEcCtD
Hydrocodone—Nausea—Doxorubicin—thyroid cancer	0.00069	0.00104	CcSEcCtD
